» News

Polpharma Santo in Media

The President held the 38th plenary session of the Foreign Investors’ Council

Detail

Polpharma Group to invest €60 mln more in Kazakhstan’s pharma industry

Detail

The use of AI in pharmaceutical manufacturing: a lecture by the head of industrial operations at Polpharma Group

Detail

Pharma companies lead the way in securing authentic medicines in Kazakhstan

Detail

Implementation of the Head of State’s Instructions: 39.5 Billion Tenge in Private Investment to Expand Pharmaceutical Production in Shymkent

Detail

Polish RNA Technology Platform

Detail

Polpharma Group Announces Leadership Transition –Sebastian Szymanek appointed as its new President

Detail

Olzhas Bektenov Discusses New Project for Expanding Pharmaceutical Production in Kazakhstan with Chairman of the Supervisory Board of Polpharma Group

Detail

Olzhas Bektenov holds Interim Meeting of Foreign Investors Council

Detail

Expanding Cooperation with Polpharma Group

Detail

Adam Aleksiejuk, SANTO: “The more viable we are on the global market, the more benefits we can give Kazakhstan”

Detail

SANTO after pandemic: outlook for domestic pharmaceutical industry

Detail

Load more posts

The President held the 38th plenary session of the Foreign Investors’ Council

Detail

Polpharma Group to invest €60 mln more in Kazakhstan’s pharma industry

Detail

The use of AI in pharmaceutical manufacturing: a lecture by the head of industrial operations at Polpharma Group

Detail

Pharma companies lead the way in securing authentic medicines in Kazakhstan

Detail

Implementation of the Head of State’s Instructions: 39.5 Billion Tenge in Private Investment to Expand Pharmaceutical Production in Shymkent

Detail

Polish RNA Technology Platform

Detail

Polpharma Group Announces Leadership Transition –Sebastian Szymanek appointed as its new President

Detail

Olzhas Bektenov Discusses New Project for Expanding Pharmaceutical Production in Kazakhstan with Chairman of the Supervisory Board of Polpharma Group

Detail

Olzhas Bektenov holds Interim Meeting of Foreign Investors Council

Detail

Expanding Cooperation with Polpharma Group

Detail

Adam Aleksiejuk, SANTO: “The more viable we are on the global market, the more benefits we can give Kazakhstan”

Detail

SANTO after pandemic: outlook for domestic pharmaceutical industry

Detail

Load more posts

The President held the 38th plenary session of the Foreign Investors’ Council

Detail

Polpharma Group to invest €60 mln more in Kazakhstan’s pharma industry

Detail

The use of AI in pharmaceutical manufacturing: a lecture by the head of industrial operations at Polpharma Group

Detail

Pharma companies lead the way in securing authentic medicines in Kazakhstan

Detail

Implementation of the Head of State’s Instructions: 39.5 Billion Tenge in Private Investment to Expand Pharmaceutical Production in Shymkent

Detail

Polish RNA Technology Platform

Detail

Polpharma Group Announces Leadership Transition –Sebastian Szymanek appointed as its new President

Detail

Olzhas Bektenov Discusses New Project for Expanding Pharmaceutical Production in Kazakhstan with Chairman of the Supervisory Board of Polpharma Group

Detail

Olzhas Bektenov holds Interim Meeting of Foreign Investors Council

Detail

Expanding Cooperation with Polpharma Group

Detail

Adam Aleksiejuk, SANTO: “The more viable we are on the global market, the more benefits we can give Kazakhstan”

Detail

SANTO after pandemic: outlook for domestic pharmaceutical industry

Detail

Load more posts

The President held the 38th plenary session of the Foreign Investors’ Council

Detail

Polpharma Group to invest €60 mln more in Kazakhstan’s pharma industry

Detail

The use of AI in pharmaceutical manufacturing: a lecture by the head of industrial operations at Polpharma Group

Detail

Pharma companies lead the way in securing authentic medicines in Kazakhstan

Detail

Implementation of the Head of State’s Instructions: 39.5 Billion Tenge in Private Investment to Expand Pharmaceutical Production in Shymkent

Detail

Polish RNA Technology Platform

Detail

Polpharma Group Announces Leadership Transition –Sebastian Szymanek appointed as its new President

Detail

Olzhas Bektenov Discusses New Project for Expanding Pharmaceutical Production in Kazakhstan with Chairman of the Supervisory Board of Polpharma Group

Detail

Olzhas Bektenov holds Interim Meeting of Foreign Investors Council

Detail

Expanding Cooperation with Polpharma Group

Detail

Adam Aleksiejuk, SANTO: “The more viable we are on the global market, the more benefits we can give Kazakhstan”

Detail

SANTO after pandemic: outlook for domestic pharmaceutical industry

Detail

Load more posts

Polpharma Santo’s life

Photo
Video

SANTO received PHARMA DIGITAL AWARDS honours such as leadership in the category of “Cold & Flu” products and bronze in the category of “Cough medicines”

View

SANTO is the market leader in Kazakhstan based on the results of the Kazakhstan pharmaceutical industry review for 2022 according to the data of Viortis independent consulting company

View